ID: ALA4799741

Max Phase: Preclinical

Molecular Formula: C6H8O6

Molecular Weight: 176.12

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C1O[C@@H]([C@@H](O)CO)C(O)=C1O

Standard InChI:  InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5-/m0/s1

Standard InChI Key:  CIWBSHSKHKDKBQ-VHUNDSFISA-N

Associated Targets(non-human)

SARS-CoV-2 38078 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 176.12Molecular Weight (Monoisotopic): 176.0321AlogP: -1.41#Rotatable Bonds: 2
Polar Surface Area: 107.22Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.36CX Basic pKa: CX LogP: -1.91CX LogD: -4.83
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.39Np Likeness Score: 2.26

References

1. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]

Source